Know Cancer

or
forgot password

Cytogenetic and Molecular Genetic Studies in Bone Sarcomas


N/A
N/A
N/A
Not Enrolling
Both
Lung Cancer

Thank you

Trial Information

Cytogenetic and Molecular Genetic Studies in Bone Sarcomas


Inclusion Criteria:



- Patients must be undergoing diagnostic biopsy or resection of their primary or
metastatic bone sarcoma for therapeutic purposes.

- The specimen must be large enough to allow routine pathological analysis, with the
specimen for research excised from residual tissue that would otherwise be discarded.

Exclusion Criteria:

- N/A

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To establish a serial ascertainement of specimens from patients with bone sarcomas to be used in ongoing cytogenetic and molecular genetic analyses.

Outcome Time Frame:

conclusion of study

Safety Issue:

No

Principal Investigator

Marc Ladanyi, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

93-141

NCT ID:

NCT00579930

Start Date:

December 1993

Completion Date:

December 2010

Related Keywords:

  • Lung Cancer
  • Bone
  • Soft Tissue
  • Lung Neoplasms
  • Osteosarcoma
  • Sarcoma

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021